Yoon Jeong Yong, Kim Paul Shinil, Jo Chris Hyunchul
Department of Orthopedic Surgery, SMG-SNU Boramae Medical Center, Seoul, Korea.
Department of Orthopedic Surgery and Translational Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea.
Clin Shoulder Elb. 2018 Jun 1;21(2):59-66. doi: 10.5397/cise.2018.21.2.59. eCollection 2018 Jun.
Massive, irreparable rotator cuff tears (RCTs) are a challenging clinical problem in young patients. In recent years, arthroscopic superior capsular reconstruction (ASCR) is a popular treatment in the massive, irreparable RCTs. However, studies reporting clinical results of ASCR are rare in the literature.
Between 2013 and 2015, six patients underwent ASCR. One patient treated with dermal allograft, while five patients with autogenous fascia lata graft. Demographic data, as well as preoperative and last follow-up clinical data including pain, range of motion (ROM), strength, American Shoulder and Elbow Surgeons system, the Constant system, the University of California at Los Angeles system, the Simple Shoulder Test, and the Shoulder Pain and Disability Index system were obtained. Acromiohumeral distances and Hamada classification were measured on standard anteroposterior x-ray.
All patients were men, and the average age was 59.5 ± 4.18 years (range, 53-65 years).The minimum follow-up was 18 months with a mean follow-up was 27.33 ± 7.58 months (range, 18-36). All patients had postoperative improvement in pain scores and functional scores. The ROM and strength did not improve after surgery. The Hamada score progressed of radiographic stage in 2 patients. In the case of dermal allograft, there was graft failure 6 weeks after ASCR.
Our results support the ASCR as a viable treatment for surgical salvage in massive, irreparable RCTs. This treatment option may provide patients with decreased pain and increased function. And studying our case of dermal allograft failure provides opportunities to decrease graft failure in ASCR using dermal allograft.
巨大的、无法修复的肩袖撕裂(RCTs)在年轻患者中是一个具有挑战性的临床问题。近年来,关节镜下上盂唇重建术(ASCR)是治疗巨大的、无法修复的RCTs的一种常用方法。然而,文献中报道ASCR临床结果的研究很少。
2013年至2015年期间,6例患者接受了ASCR。1例患者使用异体真皮移植,5例患者使用自体阔筋膜移植。收集患者的人口统计学数据,以及术前和末次随访时的临床数据,包括疼痛、活动范围(ROM)、力量、美国肩肘外科医师协会系统、Constant系统、加利福尼亚大学洛杉矶分校系统、简单肩部测试和肩痛与功能障碍指数系统。在标准前后位X线片上测量肩峰下间隙和滨田分类。
所有患者均为男性,平均年龄为59.5±4.18岁(范围53 - 65岁)。最短随访时间为18个月,平均随访时间为27.33±7.58个月(范围18 - 36个月)。所有患者术后疼痛评分和功能评分均有改善。术后ROM和力量没有改善。2例患者的滨田评分在影像学分期上有进展。在异体真皮移植的病例中,ASCR术后6周出现移植失败。
我们的结果支持ASCR作为治疗巨大的、无法修复的RCTs手术挽救的一种可行方法。这种治疗选择可能会减轻患者的疼痛并提高功能。并且研究我们异体真皮移植失败的病例为减少使用异体真皮移植的ASCR中的移植失败提供了机会。